Announced Tue, 14 Jul · 18:14 IST
Appointment of M/s Avinash Gandhewar & Associates as Secretarial Auditor for FY 2025-26
Management Changes View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.1%1-day move
₹39.50
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-1.1+3.2+1.5+3.8+4.4+1.3————
Up moveDown movePending
AI summary
Goldline Pharmaceutical Limited has appointed M/s Avinash Gandhewar & Associates, Practicing Company Secretaries (Membership No. FCS 11197), based in Nagpur, as its Secretarial Auditor for the financial year 2025-26. The appointment was approved by the Board at its meeting held on 14th July 2026. The firm is a peer-reviewed practice with experience in company law, securities laws, FEMA, and related matters.
Likely market impact
Routine compliance appointment. No material impact on shareholders or stock price.